Skip to content

PRIBE: what changed

BE 0787.283.969NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2025 and 2026

Net result for the year
€22,027
2025 · €19,529+€2,498
Equity
€76,144
2025 · €54,117+€22,027
Cash
€32,788
2025 · €11,551+€21,237
Balance sheet total
€123,987
2025 · €123,246+€741

Largest movements

2025 to 2026
Assets
  • Cash +€21,237

    up €21,237 (+184%), from €11,551 to €32,788

    mainly Net result for the year (+€22,027) and Depreciation (+€12,384)

  • Tangible fixed assets -€12,384

    down €12,384 (-31.9%), from €38,865 to €26,480

    of which Furniture and vehicles: -€11,552

  • Receivables within one year -€8,112

    down €8,112 (-35.5%), from €22,830 to €14,718

    of which Trade receivables: -€8,122

Equity and liabilities
  • Other debts -€28,207

    down €28,207 (-54.6%), from €51,678 to €23,471

  • Reserves +€22,027

    up €22,027 (+42.7%), from €51,617 to €73,644

  • Current portion of long-term debt +€10,924

    new in 2026: €10,924

  • Trade debts -€2,644

    down €2,644 (-64.0%), from €4,134 to €1,490

  • Accrued charges and deferred income -€1,885

    down €1,885 (-100%), from €1,885 to €0

Income statement
  • Gross operating margin +€7,856

    up €7,856 (+19.2%), from €40,840 to €48,696

  • Financial charges +€3,198

    up €3,198 (+113%), from €2,826 to €6,024

  • Taxes +€1,645

    up €1,645 (+28.9%), from €5,684 to €7,328

Change in the result, 2025 to 2026

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2025 €19,529
Gross operating margin +€7,856
Staff costs +€68
Depreciation -€486
Other operating charges -€91
Financial income -€6
Financial charges -€3,198
Taxes -€1,645
Result 2026 €22,027
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€10,314
Investment €0
Financing +€10,924
Cash 2025 €11,551
Net result for the year +€22,027
Depreciation +€12,384
Receivables within one year +€8,112
Trade debts -€2,644
Tax, wage and social debts +€526
Other debts -€28,207
Accrued charges and deferred income -€1,885
Current portion of long-term debt +€10,924
Cash 2026 €32,788
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2025 2026 Change %
Total assets 20/58 €123,246 €123,987 +€741 +0.6%
Fixed assets 21/28 €38,865 €26,480 -€12,384 -31.9%
Tangible fixed assets 22/27 €38,865 €26,480 -€12,384 -31.9%
Land and buildings 22 €7,981 €7,148 -€833 -10.4%
Furniture and vehicles 24 €30,884 €19,333 -€11,552 -37.4%
Current assets 29/58 €84,381 €97,507 +€13,125 +15.6%
Amounts receivable within one year 40/41 €22,830 €14,718 -€8,112 -35.5%
Trade receivables 40 €22,826 €14,703 -€8,122 -35.6%
Other amounts receivable 41 €4 €15 +€11 +255%
Current investments 50/53 €50,000 €50,000 = 0.0%
Cash at bank and in hand 54/58 €11,551 €32,788 +€21,237 +184%
Total equity and liabilities 10/49 €123,246 €123,987 +€741 +0.6%
Equity 10/15 €54,117 €76,144 +€22,027 +40.7%
Contributions 10/11 €2,500 €2,500 = 0.0%
Reserves 13 €51,617 €73,644 +€22,027 +42.7%
Distributable reserves 133 €51,617 €73,644 +€22,027 +42.7%
Amounts payable 17/49 €69,129 €47,843 -€21,286 -30.8%
Amounts payable within one year 42/48 €67,244 €47,843 -€19,401 -28.9%
Current portion of amounts payable after more than one year 42 - €10,924 +€10,924
Trade debts 44 €4,134 €1,490 -€2,644 -64.0%
Suppliers 440/4 €4,134 €1,490 -€2,644 -64.0%
Taxes, remuneration and social security 45 €11,432 €11,959 +€526 +4.6%
Taxes 450/3 €11,432 €11,959 +€526 +4.6%
Other amounts payable 47/48 €51,678 €23,471 -€28,207 -54.6%
Accrued charges and deferred income 492/3 €1,885 €0 -€1,885 -100%
Remuneration, social security and pensions 62 €68 €0 -€68 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,898 €12,384 +€486 +4.1%
Other operating charges 640/8 €841 €932 +€91 +10.8%
Gross operating margin 9900 €40,840 €48,696 +€7,856 +19.2%
Operating profit (loss) 9901 €28,033 €35,380 +€7,347 +26.2%
Financial income 75/76B €6 €0 -€6 -96.8%
Recurring financial income 75 €6 €0 -€6 -96.8%
Financial charges 65/66B €2,826 €6,024 +€3,198 +113%
Recurring financial charges 65 €2,826 €6,024 +€3,198 +113%
Profit (loss) for the period before taxes 9903 €25,213 €29,356 +€4,143 +16.4%
Income taxes 67/77 €5,684 €7,328 +€1,645 +28.9%
Profit (loss) for the period 9904 €19,529 €22,027 +€2,498 +12.8%
Profit (loss) for the period to be appropriated 9905 €19,529 €22,027 +€2,498 +12.8%

Value

latest balance sheet 31-03-2026 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€125,744 to €160,812

Midpoint €140,356 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €76,144
Capitalised earnings €175,343 to €245,480
Indication €125,744 to €160,812

Adjusted equity

balance sheet 31-03-2026
Equity (10/15)
€76,144
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€76,144

Capitalised earnings

net result for the year (9904)
2026
€22,027
2025
€19,529
2024
€32,088
Average result
€24,548
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€175,343 / €204,567 / €245,480

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 March 2025 and 31 March 2026. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.